Acadia Pharmaceuticals (NASDAQ: ACAD) aspires to become a big player in the neuroscience market. Eli Lilly (NYSE: LLY) already is one. But aside from their common interest in this therapeutic category, there's little in common between these two drugmakers.Investors considering buying shares of Acadia or Lilly have a stark contrast -- beaten-down biotech, or relatively boring big pharma.
Better Buy: Acadia Pharmaceuticals Vs. Eli Lilly
newsfeedback@fool.com (Keith Speights), The Motley Fool
Fri, 07/13/2018 - 5:17am
BING NEWS:
- Which Is a Better Investment, ACADIA Pharmaceuticals Inc or Centessa Pharmaceuticals PLC
Learn more about whether ACADIA Pharmaceuticals Inc or Centessa Pharmaceuticals PLC - ADR is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics ...
09/18/2024 - 1:43 am | View Link - US FDA approves Eli Lilly's drug for eczema
Eli Lilly said on Friday the U.S. Food and Drug Administration approved its eczema drug for use in adults and children above 12 years old.
09/13/2024 - 10:44 am | View Link - The ACADIA Pharmaceuticals Inc Enigma: What’s Causing the Wild Swings in ACAD Stock?
ACADIA Pharmaceuticals Inc (ACAD) stock saw a decline, ending the day at $16.07 which represents a decrease of $-0.15 or -0.92% from the prior close of $16.22. The stock opened at $16.32 and touched a ...
09/7/2024 - 3:36 am | View Link - Comparative Study: Eli Lilly And Industry Competitors In Pharmaceuticals Industry
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and ...
09/6/2024 - 4:00 am | View Link - More
Welcome to Wopular
Wopular is an
online newspaper rack,
giving you a summary view of the top headlines from the top news sites.
Senh Duong (Founder)
Wopular,
MWB,
RottenTomatoes
MoviesWithButter : Our Sister Site
- "Expendables 4" Starts Shooting This Fall, Says Randy Couture at the Arnold Sports Festival more
- “Expendables 4” Gets Funding Interest from “Ip Man 3” Financier more
- "Ip Man 3" Distributor Suspected of Box Office Fraud, Parent Company Loses $200M in Market Cap more
- Yen Targets "Ip Man 4" for 2018 Release; Discusses Film with Director, Producer more
- "Ip Man 3" Shatters Expectations with $72M Opening [China Box Office] more